应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NVS 诺华
圣诞节休市 12-24 13:00:00 EST
138.88
-0.25
-0.18%
盘后
138.88
+0.00
0.00%
16:56 EST
最高
139.48
最低
138.53
成交量
64.69万
今开
139.06
昨收
139.13
日振幅
0.68%
总市值
2,689亿
流通市值
2,561亿
总股本
19.36亿
成交额
8,985万
换手率
0.04%
流通股本
18.44亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免
华尔街见闻 · 12-20
特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
智通财经 · 12-20
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
美股速递 · 12-20
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
中国同辐(01763)附属原子高科与诺华公司签署商业合作协议
智通财经 · 12-15
中国同辐(01763)附属原子高科与诺华公司签署商业合作协议
美股异动丨诺华制药盘前涨近2%，布局过敏性疾病新靶点
格隆汇 · 12-09
美股异动丨诺华制药盘前涨近2%，布局过敏性疾病新靶点
诺华制药(NVS.US)17亿美元押注英国AI药企 布局过敏性疾病新靶点
智通财经 · 12-09
诺华制药(NVS.US)17亿美元押注英国AI药企 布局过敏性疾病新靶点
大摩：将诺华制药目标价上调至115瑞士法郎
中金财经 · 12-03
大摩：将诺华制药目标价上调至115瑞士法郎
诺华慢性自发性荨麻疹创新药物瑞普多（瑞米布替尼片）在华获批
南方财经网 · 11-26
诺华慢性自发性荨麻疹创新药物瑞普多（瑞米布替尼片）在华获批
诺华计划2027年底前在瑞士裁员550人
格隆汇 · 11-25
诺华计划2027年底前在瑞士裁员550人
诺华中国回应解散县域团队传闻
南方财经网 · 11-25
诺华中国回应解散县域团队传闻
诺华同意收购RNA疗法创新企业Avidity Biosciences，以强化其后期阶段的神经科学管线
动脉网 · 11-25
诺华同意收购RNA疗法创新企业Avidity Biosciences，以强化其后期阶段的神经科学管线
美国FDA批准诺华基因疗法治疗罕见肌肉疾病
格隆汇 · 11-25
美国FDA批准诺华基因疗法治疗罕见肌肉疾病
诺华制药预计2030年销售增长至多6%，上调主要癌症药物销售预测
格隆汇 · 11-20
诺华制药预计2030年销售增长至多6%，上调主要癌症药物销售预测
诺华(NVS)拟在美国北卡罗来纳州新建制造中心
金吾财讯 · 11-20
诺华(NVS)拟在美国北卡罗来纳州新建制造中心
诺华制药(NVS.US)上调两大抗癌药销售峰值预测 预计推动2030年前营收年均增长5%-6%
智通财经 · 11-20
诺华制药(NVS.US)上调两大抗癌药销售峰值预测 预计推动2030年前营收年均增长5%-6%
诺华将在美国北卡罗来纳州新建制造中心
格隆汇 · 11-20
诺华将在美国北卡罗来纳州新建制造中心
诺华制药：将在北卡罗来纳州打造一座旗舰级生产中心，该中心可在单一地点生产涵盖所有主要治疗领域的药品
新浪财经 · 11-20
诺华制药：将在北卡罗来纳州打造一座旗舰级生产中心，该中心可在单一地点生产涵盖所有主要治疗领域的药品
诺华制药盘中异动 急速下挫3.18%
市场透视 · 11-18
诺华制药盘中异动 急速下挫3.18%
港股异动 | 中国同辐(01763)再涨超8% 诺华核药在华获批上市 有望点燃国内核医学行业热度
智通财经 · 11-12
港股异动 | 中国同辐(01763)再涨超8% 诺华核药在华获批上市 有望点燃国内核医学行业热度
进博首日旗下核药获批上市 诺华迎来开门红
国际金融报 · 11-08
进博首日旗下核药获批上市 诺华迎来开门红
加载更多
公司概况
公司名称：
诺华
所属市场：
NYSE
上市日期：
--
主营业务：
Novartis AG于1996年2月29日在瑞士成立。该公司是一家创新药物公司，从事各种创新药物的研究、开发、制造、分销、营销和销售。该公司的宗旨是利用其科学专业知识寻找治疗和治愈疾病的新方法，重新构想医学，以改善和延长人们的生命。该公司的业务分为五个组织部门：生物医学研究、开发、运营和两个商业部门（美国和国际）。全球职能部门支持这些组织部门开展工作。该公司专注于四个具有强大增长潜力和大量未满足患者需求的核心治疗领域—心血管、肾脏和代谢；免疫学；神经科学；和肿瘤学。
发行价格：
--
{"stockData":{"symbol":"NVS","market":"US","secType":"STK","nameCN":"诺华","latestPrice":138.88,"timestamp":1766599200000,"preClose":139.13,"halted":0,"volume":646948,"hourTrading":{"tag":"盘后","latestPrice":138.88,"preClose":138.88,"latestTime":"16:56 EST","volume":39233,"amount":5447667.5694,"timestamp":1766613385675},"delay":0,"floatShares":1843882545,"shares":1935853188,"eps":7.299003,"marketStatus":"圣诞节休市","change":-0.25,"latestTime":"12-24 13:00:00 EST","open":139.06,"high":139.48,"low":138.53,"amount":89853727.87072,"amplitude":0.006828,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.299003,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766739600000},"marketStatusCode":7,"adr":1,"adrRate":1,"exchange":"NYSE","adjPreClose":139.13,"dividendRate":0.027811,"preHourTrading":{"tag":"盘前","latestPrice":134.41,"preClose":139.13,"latestTime":"09:20 EST","volume":26,"amount":3608.579,"timestamp":1766586030749},"postHourTrading":{"tag":"盘后","latestPrice":138.88,"preClose":138.88,"latestTime":"16:56 EST","volume":39233,"amount":5447667.5694,"timestamp":1766613385675},"volumeRatio":0.688154,"impliedVol":0.2001,"impliedVolPercentile":0.048},"requestUrl":"/m/hq/s/NVS","defaultTab":"news","newsList":[{"id":"2592192144","title":"特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免","url":"https://stock-news.laohu8.com/highlight/detail?id=2592192144","media":"华尔街见闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592192144?lang=zh_cn&edition=full","pubTime":"2025-12-20 08:48","pubTimestamp":1766191729,"startTime":"0","endTime":"0","summary":"默沙东、诺华、葛兰素史克等九家药企签署协议后，特朗普称，今夏被政府盯上的17家药企中已有14家同意“大幅”降价。美商务部长暗示，剩余三家将在年末假期后宣布类似的协议。","market":"sg","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3761750","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3761750","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","MRK","NVS"],"gpt_icon":1},{"id":"2592139231","title":"默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139231?lang=zh_cn&edition=full","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际，多家美国及欧洲大型制药企业近日与白宫达成协议，同意自愿下调在美销售的药品价格，以换取关税豁免和政策支持。在此次协议中，最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示，今年7月他致信要求降价的17家大型制药企业中，已有14家同意大幅下调药价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2acbaf8fbf691a451fa9ea170ee88816","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["JNJ","LU0203347892.USD","LU1261432733.SGD","LU1670711040.USD","LU1868836591.USD","LU0130517989.USD","LU0456855351.SGD","SNY","LU1037948541.HKD","LU1989772923.USD","LU0122379950.USD","BK4516","LU1974910355.USD","LU0006306889.USD","LU1035773651.USD","REGN","LU1989771016.USD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0965508806.USD","LU0985481810.HKD","LU2106854487.HKD","LU2360032135.SGD","LU2361045086.USD","LU0289739699.SGD","LU0320765646.SGD","LU1934455277.USD","LU1430594728.SGD","LU0114720955.EUR","AMGN","NVS","LU1670711123.USD","IE0009355771.USD","SG9999014567.USD","LU2324357040.USD","LU2461242641.AUD","LU2133065610.SGD","LU0265550946.USD","LU0861579265.USD","LU1093756168.USD","LU1934455863.HKD","LU0320765489.SGD","LU1699723380.USD","LU0648001328.SGD","LU0965509010.AUD","LU2242646821.SGD","IE00BFXG1179.USD","LU0980610538.SGD","LU0061475181.USD","LU2112291526.USD","LU2125154935.USD","LU1069347547.HKD","BK4007","IE00BLSP4239.USD","LU0208291251.USD","BK4559","LU1718418525.SGD","IE00B1BXHZ80.USD","SG9999013999.USD","LU0070302665.USD","LU0211331839.USD","BMY","LU0882574055.USD","LU1162221912.USD","LU1670710588.SGD","LU1868836914.USD","LU0225771236.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU1093756325.SGD","LU1585245621.USD","LU0225284248.USD","BK4581","IE00B2B36J28.USD","LU1941712264.USD","LU0203345920.USD","LU1571399168.USD","BK4532","LU1074936037.SGD","SG9999002224.SGD","BK4534","LU0868494617.USD","SG9999001440.SGD","LU1116320737.USD","LU0306806265.USD","LU0130102774.USD","ABBV","LU0237698245.USD","SGXZ57979304.SGD","LU0234572021.USD","LU0321505439.SGD","LU2242652126.USD","LU0096364046.USD","IE00BJJMRZ35.SGD","LU1323610961.USD","IE00BBT3K403.USD","LU0965509283.SGD","IE00B4R5TH58.HKD","BK4533","LU2361044949.HKD","LU0098860793.USD","LU0266013472.USD","LU1868837136.USD","GSK","SG9999014575.USD","SG9999014542.SGD","LU2125154778.USD","LU0965509101.SGD","LU1066051811.HKD","SG9999002232.USD","IE000M9KFDE8.USD","LU1201861249.SGD","GILD","LU1934455194.USD","IE00BSNM7G36.USD","LU1116320901.HKD","LU1929549753.HKD","LU0321505868.SGD","LU0985320562.USD","LU1023059063.AUD","LU1061106388.HKD","BK4550","04332","LU0265550359.USD","LU1066051225.USD","LU1057294990.SGD","LU2089984988.USD","LU1066051498.USD","LU1989772840.SGD","LU2023250843.SGD","LU1037948897.HKD","BK4585","LU1032466523.USD","MRK","SG9999015341.SGD","BK4588","LU1941712348.USD","LU2468319806.SGD","LU0238689110.USD","LU1917777945.USD","LU0106261372.USD","LU0306807586.USD","LU1291159041.SGD","IE0002141913.USD","SG9999001176.SGD","ROG","SG9999015358.SGD","LU1868837300.USD","LU1983299246.USD","LU1868836757.USD","LU0267386448.USD","LU1066053197.SGD","LU1670710661.SGD","SG9999014559.SGD","AZN","SG9999001176.USD","LU2023250504.SGD","IE00BN8TJ469.HKD","LU2361044865.SGD","LU0477156953.USD"],"gpt_icon":1},{"id":"1190397083","title":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1190397083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190397083?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:22","pubTimestamp":1766172127,"startTime":"0","endTime":"0","summary":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1302929846.USD","IE00B19Z3581.USD","LU0648001328.SGD","LU1645745479.HKD","SG9999002224.SGD","LU0823416689.USD","LU2112291526.USD","BK4559","IE0034235071.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU1674673428.USD","LU0098860793.USD","LU1571399168.USD","LU2089984988.USD","SG9999001176.USD","LU0965509101.SGD","LU1868836914.USD","LU1989771016.USD","LU0122379950.USD","LU1032466523.USD","LU0965509010.AUD","LU1917777945.USD","LU1585245621.USD","GSK","LU0208291251.USD","LU1718418525.SGD","BK4534","LU1400636574.HKD","LU0545562505.USD","SG9999001176.SGD","LU1934455194.USD","LU1487256676.USD","LU1699723380.USD","LU0109394709.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU0971552830.HKD","LU0889565916.HKD","LU1941712264.USD","IE0002270589.USD","LU1261432733.SGD","LU1323610961.USD","SG9999014575.USD","LU1116320737.USD","LU0861579265.USD","IE00BLSP4452.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","GILD","LU1868836757.USD","LU1066051811.HKD","LU2242646821.SGD","IE00BQJZX424.USD","LU1035773651.USD","LU1430594728.SGD","IE00BLSP4239.USD","LU1670711123.USD","RHHBY","IE0002141913.USD","SG9999015952.SGD","SGXZ57979304.SGD","IE00B7SZLL34.SGD","LU0980610538.SGD","BK4533","LU0306806265.USD","BK4550","LU0225284248.USD","LU2125154935.USD","BK4516","LU1066051225.USD","LU1061106388.HKD","LU2087621335.USD","SG9999001440.SGD","IE00B1BXHZ80.USD","LU0096364046.USD","IE00BBT3K403.USD","LU0265550946.USD","LU1093756168.USD","BK4599","04332","LU1674673691.USD","LU1868837136.USD","LU0058720904.USD","LU2242652126.USD","LU1015430645.USD","LU0237698245.USD","IE00BSNM7G36.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU1670756490.USD","BK4585","LU1778281490.HKD","LU1868836591.USD","IE00BN8TJ469.HKD","LU1309081286.SGD","LU0070302665.USD","LU1481600234.SGD","LU1098665638.USD","LU2023250504.SGD","BMY","LU0477156953.USD","LU1074936037.SGD","SG9999014567.USD","LU0106261372.USD","IE00B4R5TH58.HKD","LU1228905540.USD","LU1066053197.SGD","BK4578","LU0061475181.USD","LU0211331839.USD","LU0289739699.SGD","BK4566","LU1868837300.USD","LU2023250843.SGD","SG9999015945.SGD","LU0234570918.USD","NVS","LU1066051498.USD","LU0306807586.USD","LU0965508806.USD","BK4532","LU0267386448.USD","LU0456855351.SGD","LU1934455863.HKD","LU1037948541.HKD","LU2324357040.USD","LU1023059063.AUD","LU0238689110.USD","LU0109981661.USD","LU0130517989.USD","LU0868494617.USD","LU1201861249.SGD","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","LU0321505439.SGD","LU0985481810.HKD","BK4007","SG9999014559.SGD","IE00BWDBJ516.SGD","LU1670710661.SGD","IE0009355771.USD","LU0321505868.SGD","BK5011","LU2360032135.SGD","SG9999015986.USD","LU0234572021.USD","LU1839511570.USD","LU1400636657.SGD","LU0265550359.USD","LU1934455277.USD","AMGN","LU1035777561.USD","LU0161305163.EUR","LU1057294990.SGD","LU0006306889.USD","LU0203345920.USD","LU2361045086.USD","LU1929549753.HKD","LU1481599808.USD","LU0320765489.SGD","LU0203347892.USD","BK4588","LU1162221912.USD","LU1989772923.USD","LU0320765646.SGD","LU0225771236.USD","BK4139","BK4581","SNY","LU0882574055.USD","SG9999014542.SGD","SG9999013999.USD","LU1064927863.SGD","LU2361044949.HKD","LU0965509283.SGD","LU2133065610.SGD","SG9999002232.USD","BK4583","LU1941712348.USD","IE00B3T34201.USD","LU2125154778.USD","BIIB","LU1116320901.HKD","LU1228905037.USD","IE00BJT1NW94.SGD","LU2461242641.AUD","LU1291159041.SGD","SG9999015358.SGD","LU1046248800.SGD","LU1670711040.USD","LU0985320562.USD","LU2106854487.HKD","BK4568","LU1974910355.USD","LU0266013472.USD","MRK","LU1069347547.HKD","LU1670710588.SGD","LU0971552673.USD","LU2361044865.SGD","SG9999015978.USD","LU0575583348.USD","LU1983299246.USD","LU1989772840.SGD","LU1037948897.HKD","LU1202635105.USD","SG9999015341.SGD","IE000M9KFDE8.USD","LU1400636491.USD","LU0130102774.USD"],"gpt_icon":0},{"id":"2591649704","title":"中国同辐(01763)附属原子高科与诺华公司签署商业合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649704","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591649704?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:15","pubTimestamp":1765804518,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，本公司附属公司原子高科股份有限公司(原子高科)与诺华医药科技(浙江)有限公司(诺华公司)正式签署派威妥®(镥[177Lu]特昔维匹肽注射液)商业合作协议(商业合作协议)。派威妥® 是国内首个且目前唯一获批的靶向PSMA的放射配体疗法药物，主要用于治疗晚期前列腺癌，未来将为患者提供延长生命并改善生活质量的全新核药治疗方案。此次签约开启了双方在创新核药产品派威妥®方面的战略合作，原子高科将凭藉在放射性药物领域的多年合规运营经验，与诺华公司强强联合，为医疗机构和患者提供定制化的派威妥®产品供应与解决方案，以惠及更多的患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","IE00BJT1NW94.SGD","BK4588","IE00B2B36J28.USD","IE0009355771.USD","BK4532","NVS","BK4578","IE00B4R5TH58.HKD","LU0070302665.USD","LU0211331839.USD","BK1222","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4007","LU0320765489.SGD","LU0208291251.USD","IE00BFTCPJ56.SGD","BK4585"],"gpt_icon":0},{"id":"2590311199","title":"美股异动丨诺华制药盘前涨近2%，布局过敏性疾病新靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=2590311199","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590311199?lang=zh_cn&edition=full","pubTime":"2025-12-09 17:27","pubTimestamp":1765272424,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0211331839.USD","01477","NVS","IE00BJJMRZ35.SGD","BK4532","BK4578","IE0009355771.USD","BK1574","LU0070302665.USD","IE0002141913.USD","BK4585","BK4007","BK4588","LU0208291251.USD","BK1191","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2590390096","title":"诺华制药(NVS.US)17亿美元押注英国AI药企 布局过敏性疾病新靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=2590390096","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590390096?lang=zh_cn&edition=full","pubTime":"2025-12-09 15:03","pubTimestamp":1765263792,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药将支付英国生物技术公司 Relation Therapeutics Ltd. 高达 17 亿美元，以帮助寻找治疗过敏性疾病的药物靶点。今年早些时候，诺华制药同意以 14 亿美元收购 Tourmaline Bio 公司，从而获得一种有望减轻全身性炎症的治疗方法。该公司还同意以最高 17 亿美元的价格收购美国生物技术公司 Regulus Therapeutics，并通过收购美国生物技术公司 Anthos Therapeutics 进一步丰富其心脏病学产品组合，以获得一种预防中风的药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","IE00BFTCPJ56.SGD","BK4532","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4588","IE00B2B36J28.USD","BK1574","BK4578","NVS","LU0211331839.USD","BK4007","LU0208291251.USD","IE0009355771.USD","LU0320765489.SGD","BK1191","01477","LU0070302665.USD"],"gpt_icon":0},{"id":"2588013596","title":"大摩：将诺华制药目标价上调至115瑞士法郎","url":"https://stock-news.laohu8.com/highlight/detail?id=2588013596","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588013596?lang=zh_cn&edition=full","pubTime":"2025-12-03 15:17","pubTimestamp":1764746221,"startTime":"0","endTime":"0","summary":"摩根士丹利：将诺华制药目标价从110瑞士法郎上调至115瑞士法郎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251203/31841213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["NVS","01477"],"gpt_icon":0},{"id":"2586284416","title":"诺华慢性自发性荨麻疹创新药物瑞普多（瑞米布替尼片）在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2586284416","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586284416?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:56","pubTimestamp":1764125818,"startTime":"0","endTime":"0","summary":"南方财经11月26日电，诺华公司今日宣布，其创新药物瑞普多?（瑞米布替尼片）获得国家药品监督管理局批准，适用于H1抗组胺药控制不充分的成人慢性自发性荨麻疹（CSU）患者。瑞米布替尼片的获批有望构建CSU治疗新格局，开启口服小分子靶向治疗*新篇章，为中国超过千万长期饱受CSU困扰的患者带来治疗新选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511263575225572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","LU0070302665.USD","BK4007","BK4585","IE00BJT1NW94.SGD","BK1161","BK4588","LU0211331839.USD","BK4532","IE00B2B36J28.USD","06978","BK4578","LU0320765489.SGD","IE00BJJMRZ35.SGD","LU0208291251.USD","IE0002141913.USD","IE00B4R5TH58.HKD","159992","NVS","BK1574"],"gpt_icon":0},{"id":"2586429344","title":"诺华计划2027年底前在瑞士裁员550人","url":"https://stock-news.laohu8.com/highlight/detail?id=2586429344","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586429344?lang=zh_cn&edition=full","pubTime":"2025-11-25 18:02","pubTimestamp":1764064931,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BFTCPJ56.SGD","BK4578","IE00BJJMRZ35.SGD","LU0070302665.USD","LU0211331839.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0208291251.USD","BK4585","BK4588","BK4007","NVS","IE00BJT1NW94.SGD","BK4532","IE00B2B36J28.USD","LU0320765489.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2586449251","title":"诺华中国回应解散县域团队传闻","url":"https://stock-news.laohu8.com/highlight/detail?id=2586449251","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586449251?lang=zh_cn&edition=full","pubTime":"2025-11-25 13:44","pubTimestamp":1764049489,"startTime":"0","endTime":"0","summary":"南方财经11月25日电，据界面新闻，有消息称诺华中国区县域团队将整体解散，最后工作日定为12月31日。对此，诺华回应称，为持续服务中国县域医疗市场，自2026年1月1日起，诺华公司将对县域业务运营模式进行调整。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511253574099255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0211331839.USD","BK4007","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0070302665.USD","LU0208291251.USD","IE0009355771.USD","IE00B2B36J28.USD","NVS","BK4532","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4585","LU0320765489.SGD","BK4578","BK4588"],"gpt_icon":0},{"id":"2586244925","title":"诺华同意收购RNA疗法创新企业Avidity Biosciences，以强化其后期阶段的神经科学管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2586244925","media":"动脉网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586244925?lang=zh_cn&edition=full","pubTime":"2025-11-25 12:36","pubTimestamp":1764045360,"startTime":"0","endTime":"0","summary":"诺华宣布收购RNA疗法企业Avidity Biosciences，收购将在Avidity分拆早期心脏疾病项目后进行。此次收购契合诺华深耕神经科学的战略，有望填补遗传性疾病治疗空白，扩展公司管线。Avidity项目包含潜在同类首创、处于临床试验后期阶段的疾病修饰疗法，适用于多种罕见神经肌肉疾病。基于诺华专业经验及商业化能力，此次收购有望打造行业领先研发管线，AOC平台将单抗组织特异性与寡核苷酸精准调控结合，有望改变疾病进程，对患者生活产生积极影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125125311977ddcf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125125311977ddcf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00BJT1NW94.SGD","LU0211331839.USD","BK4578","BK4588","BK4139","IE0009354923.USD","LU0070302665.USD","BK4532","IE00BJJMRZ35.SGD","NVS","IE00B4R5TH58.HKD","IE0009355771.USD","RNA","IE0002141913.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4505","IE00B2B36J28.USD","BK4585"],"gpt_icon":0},{"id":"2586416462","title":"美国FDA批准诺华基因疗法治疗罕见肌肉疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=2586416462","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586416462?lang=zh_cn&edition=full","pubTime":"2025-11-25 07:46","pubTimestamp":1764028013,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0211331839.USD","BK4007","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0070302665.USD","LU0208291251.USD","IE0009355771.USD","IE00B2B36J28.USD","NVS","BK4532","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4585","LU0320765489.SGD","BK4578","BK4588"],"gpt_icon":0},{"id":"2584013917","title":"诺华制药预计2030年销售增长至多6%，上调主要癌症药物销售预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2584013917","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584013917?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:33","pubTimestamp":1763642002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","01477","IE0002141913.USD","BK1191","BK4578","LU0211331839.USD","NVS","BK4585","BK4588","BK4007","LU0208291251.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0320765489.SGD","BK4532","IE00B2B36J28.USD","LU0070302665.USD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2584825041","title":"诺华(NVS)拟在美国北卡罗来纳州新建制造中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2584825041","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584825041?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:15","pubTimestamp":1763630119,"startTime":"0","endTime":"0","summary":"金吾财讯 | 瑞士诺华公司(NVS)表示，将扩大在美国北卡罗来纳州的业务，计划建立一个制造中心，作为未来五年在美国投资230亿美元基础设施计划的一部分。诺华指出，预计于2027年或2028年启用的新中心，将包括位于北卡罗来纳州达勒姆的两座新设施，用于生物制剂生产和无菌包装，以及位于莫里斯维尔的固体制剂生产及包装设施。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"294640","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4588","IE00B2B36J28.USD","BK4532","LU0211331839.USD","BK4585","NVS","BK4007","IE0002141913.USD","LU0320765489.SGD","IE0009355771.USD","BK4578","LU0070302665.USD","LU0208291251.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2584850381","title":"诺华制药(NVS.US)上调两大抗癌药销售峰值预测 预计推动2030年前营收年均增长5%-6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584850381","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584850381?lang=zh_cn&edition=full","pubTime":"2025-11-20 15:42","pubTimestamp":1763624526,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药预计，到 2030 年，经汇率调整后的销售额将增长 5%至 6%。这得益于其抗癌药物 Kisqali 和 Scemblix 的营收预期将达到更高水平。这家制药公司上调了 Kisqali的峰值销售额预测，从之前的 80 亿美元上调至至少 100 亿美元。该公司表示，其八款最具潜力的获批药物每款的潜在销售峰值都在 30 亿至 100 亿美元之间。该公司曾表示，此次收购计划将使其 2024 至 2029 年的年销售额增长率预测提高到 6%，高于此前预期的 5%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVS","01477"],"gpt_icon":0},{"id":"2584970031","title":"诺华将在美国北卡罗来纳州新建制造中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2584970031","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584970031?lang=zh_cn&edition=full","pubTime":"2025-11-20 09:13","pubTimestamp":1763601225,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4588","IE00B2B36J28.USD","BK4532","LU0211331839.USD","BK4585","NVS","BK4007","IE0002141913.USD","LU0320765489.SGD","IE0009355771.USD","BK4578","LU0070302665.USD","LU0208291251.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2584189254","title":"诺华制药：将在北卡罗来纳州打造一座旗舰级生产中心，该中心可在单一地点生产涵盖所有主要治疗领域的药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2584189254","media":"新浪财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584189254?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:39","pubTimestamp":1763573955,"startTime":"0","endTime":"0","summary":"诺华制药：将在北卡罗来纳州打造一座旗舰级生产中心，该中心可在单一地点生产涵盖所有主要治疗领域的药品。在北卡罗来纳州的扩张计划到 2030 年将创造 700 个就业岗位，旗舰中心将于 2027-2028 年开业。新的生产中心将提高生产能力，并使其所有关键药物都能在美国完成端到端的生产，这是该公司未来五年在美国基础设施投资 230 亿美元的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120014825a704e0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120014825a704e0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0070302665.USD","LU0211331839.USD","IE00B4R5TH58.HKD","BK4532","BK4588","BK4578","LU0208291251.USD","IE0009355771.USD","NVS","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4585","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4007"],"gpt_icon":0},{"id":"2584910436","title":"诺华制药盘中异动 急速下挫3.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584910436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584910436?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:31","pubTimestamp":1763476291,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时31分，诺华制药股票出现异动，股价急速下跌3.18%。截至发稿，该股报127.37美元/股，成交量7.9284万股，换手率0.00%，振幅0.47%。机构评级方面，在所有28家参与评级的机构中，25%的券商给予买入建议，57%的券商给予持有建议，18%的券商给予卖出建议。诺华制药股票所在的制药行业中，整体跌幅为0.07%。诺华制药公司简介：诺华开发和生产创新药物。该公司的产品销往全球，其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223131a4aa863a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223131a4aa863a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","IE0009355771.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0208291251.USD","LU0211331839.USD","BK4532","BK4585","IE00BJJMRZ35.SGD","LU0320765489.SGD","IE00B2B36J28.USD","LU0070302665.USD","NVS","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","BK4588","BK4007"],"gpt_icon":0},{"id":"2582310965","title":"港股异动 | 中国同辐(01763)再涨超8% 诺华核药在华获批上市 有望点燃国内核医学行业热度","url":"https://stock-news.laohu8.com/highlight/detail?id=2582310965","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582310965?lang=zh_cn&edition=full","pubTime":"2025-11-12 10:55","pubTimestamp":1762916116,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国同辐再涨超8%，年内股价累涨逾130%。截至发稿，涨7.94%，报24.48港元，成交额1302.97万港元。消息面上，11月5日，诺华宣布其放射配体疗法药物Pluvicto的两个适应症同时获得国家药监局批准。据悉，Pluvicto为诺华旗下的一款核药爆品。平安证券指出，Pluvicto的获批有望进一步点燃国内核医学行业热度，AD诊断核药有望随着治疗药物一同放量，建议关注国内在新核素和新靶点方面布局领先的企业，比如中国同辐等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0070302665.USD","IE0009355771.USD","IE0002141913.USD","LU0208291251.USD","01763","IE00BJJMRZ35.SGD","LU0211331839.USD","BK4578","IE00BJT1NW94.SGD","BK4585","BK4007","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","NVS","BK4588","BK4532","LU0320765489.SGD","BK1222"],"gpt_icon":0},{"id":"2581859013","title":"进博首日旗下核药获批上市 诺华迎来开门红","url":"https://stock-news.laohu8.com/highlight/detail?id=2581859013","media":"国际金融报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581859013?lang=zh_cn&edition=full","pubTime":"2025-11-08 13:32","pubTimestamp":1762579961,"startTime":"0","endTime":"0","summary":"11月7日，记者从瑞士制药巨头诺华公司获悉，在第八届进博会开幕首日，该公司首个放射配体疗法药物（RLT）镥[177Lu]特昔维匹肽注射液（商品名：派威妥）双适应症同时获得国家药监局批准上市，这也是国内首个获批的靶向前列腺特异性膜抗原的放射配体疗法药物，为中国晚期前列腺患者带来新的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511083558860536.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511083558860536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BJT1NW94.SGD","IE0002141913.USD","LU0070302665.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","BK4578","LU0320765489.SGD","BK4532","BK4585","NVS","BK4588","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU0211331839.USD","BK4007","IE00BFTCPJ56.SGD","IE0009355771.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novartis.com","stockEarnings":[{"period":"1week","weight":0.0285},{"period":"1month","weight":0.0975},{"period":"3month","weight":0.1362},{"period":"6month","weight":0.1572},{"period":"1year","weight":0.4121},{"period":"ytd","weight":0.4272}],"compareEarnings":[{"period":"1week","weight":0.0283},{"period":"1month","weight":0.0324},{"period":"3month","weight":0.0491},{"period":"6month","weight":0.1227},{"period":"1year","weight":0.1481},{"period":"ytd","weight":0.178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novartis AG于1996年2月29日在瑞士成立。该公司是一家创新药物公司，从事各种创新药物的研究、开发、制造、分销、营销和销售。该公司的宗旨是利用其科学专业知识寻找治疗和治愈疾病的新方法，重新构想医学，以改善和延长人们的生命。该公司的业务分为五个组织部门：生物医学研究、开发、运营和两个商业部门（美国和国际）。全球职能部门支持这些组织部门开展工作。该公司专注于四个具有强大增长潜力和大量未满足患者需求的核心治疗领域—心血管、肾脏和代谢；免疫学；神经科学；和肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.011336},{"month":2,"riseRate":0.44,"avgChangeRate":-0.010046},{"month":3,"riseRate":0.52,"avgChangeRate":0.001443},{"month":4,"riseRate":0.72,"avgChangeRate":0.018717},{"month":5,"riseRate":0.68,"avgChangeRate":0.009252},{"month":6,"riseRate":0.576923,"avgChangeRate":0.011998},{"month":7,"riseRate":0.692308,"avgChangeRate":0.011407},{"month":8,"riseRate":0.423077,"avgChangeRate":0.001152},{"month":9,"riseRate":0.692308,"avgChangeRate":0.009673},{"month":10,"riseRate":0.423077,"avgChangeRate":-0.013123},{"month":11,"riseRate":0.615385,"avgChangeRate":0.016411},{"month":12,"riseRate":0.692308,"avgChangeRate":0.020933}],"exchange":"NYSE","name":"诺华","nameEN":"Novartis AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺华,NVS,诺华股票,诺华股票老虎,诺华股票老虎国际,诺华行情,诺华股票行情,诺华股价,诺华股市,诺华股票价格,诺华股票交易,诺华股票购买,诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}